Question

Which of the following is a potential adverse effect when taking a tumor necrosis factor blocking agent (e.g., etanercept)?

Question 6 options:

	a) Sexual dysfunction.
	b) Headaches.
	c) Diarrhea.
	d) Infections.

Question 7 (1.25 points)

Which of the following is NOT an adverse effect of corticosteroids?

Question 7 options:

	a) Hypertension.
	b) Water retention (edema).
	c) Upset stomach.
	d) Hypotension.

Question 8 (1.25 points)

Just like prescription drugs dietary supplements have to prove safety and efficacy to the Food and Drug Administration.

Question 8 options:

	True
	False

Question 9 (1.25 points)

Rivastigmine (Exelon) and donepezil (Aricept) work to treat Alzheimer's Disease by increasing the levels of which of the following neurotransmitters?

Question 9 options:

	a) Acetylcholine.
	b) Dopamine.
	c) Epinephrine.
	d) Histamine.

Question 10 (1.25 points)

Which of the following best describes the mechanism of action of octreotide?

Question 10 options:

	a) Beta-2 agonist.
	b) Stimulates the release of cortisol.
	c) Inhibits insulin and growth hormone secretion.
	d) Stimulates the release of thyroxine and triiodothyronine.

Question 11 (1.25 points)

Vinca alkaloids (e.g., vincristine) should never be given intrathecally because they will lead fatal neuropathies.

Question 11 options:

	True
	False

Question 12 (1.25 points)

Amphetamines are controlled substances, but rarely lead to addiction or abuse.

Question 12 options:

	True
	False

Question 13 (1.25 points)

Please match the correct mechanism of action to the correct drug.

Question 13 options:

1234 Atomoxetine (Strattera). 1234 Guanfacine Extended Release (Intuniv). 1234 Amphetamine /Dextroamphetamine Mixture (Adderall). 1234 Modafinil (Provigil).

1. Decreases the effects of GABA. 2. Selective norepinephrine reuptake inhibitor. 3. Alpha-2 Agonist. 4. Releases norepinephrine and dopamine and blocks the reuptake of norepinephrine and dopamine.

Question 14 (1.25 points)

Which of the following medications can be used to treat extrapyramidal symptoms (drug-induced parkinsonism)?

Question 14 options:

	a) Entacapone (Comtan).
	b) Benztropine (Cogentin).
	c) Amantadine (Symmetrel).
	d) Levodopa-carbidopa (Sinemet).

Question 15 (1.25 points)

Tricyclic Antidepressants are rarely used for the treatment of depression and are more commonly used for insomnia or neuropathic pain.

Question 15 options:

	True
	False

Question 16 (1.25 points)

Which of the following is NOT an adverse effect of iron?

Question 16 options:

	a) Constipation.
	b) Diarrhea.
	c) Nausea and vomiting.
	d) Dark stools.

Question 17 (1.25 points)

Atropine is given prior to the administration of irinotecan to prevent this adverse effect.

Question 17 options:

	a) Constipation.
	b) Diarrhea.
	c) Bradycardia.
	d) Seizures.

Question 18 (1.25 points)

All corticosteroids have the same degree of potency.

Question 18 options:

	True
	False

Question 19 (1.25 points)

Which of the following is the preferred treatment for status epilepticus?

Question 19 options:

	a) Lacosamide (Vimpat).
	b) Lorazepam (Ativan).
	c) Lamotrigine (Lamictal).
	d) Ethosuximide (Zarontin).

Question 20 (1.25 points)

Which of the following lab values should be monitored while taking lithium?

Question 20 options:

	a) Lithium levels and serum creatinine.
	b) Lithium levels and liver enzymes.
	c) Serum creatinine and liver enzymes.
	d) No monitoring of lab values is required.

Question 21 (1.25 points)

Pembrolizumab (Keytruda) is an anti-CD-20 Monoclonal antibody.

Question 21 options:

	True
	False

Question 22 (1.25 points)

Antidepressants will take ______________ to achieve their full therapeutic effect.

Question 22 options:

	a) 3-4 months.
	b) 3-4 days.
	c) 4-6 weeks.
	d) 4-6 days.

Answer 1

6. Answer Option C. Infections

Option C is correct as tumor necrosis factor blocking agents often have side effects which are serious and can be seen with infections and infection like symptoms in in the patients receiving the treatment

Option A is incorrect as sexual dysfunction is not an adverse event seen in tumor necrosis factor blocking agents

Option B is incorrect as headache is a general adverse event and not very particular to tumor necrosis factor blocking agents

Option D is incorrect as diarrhoea is an was event seen in medication similar to tumor necrosis factor blocking agents but not particularly restricted to them

7. Answer Option D. Hypotension

Option D is incorrect as hypertension or low blood pressure is not an adverse event observed with corticosteroid treatment

Option A is incorrect as hypertension or higher blood pressure is a designated a known side effect of corticosteroids

Option B is incorrect as water retention or edema is an adverse event a side effect observed with corticosteroid

Option C is incorrect as stomach upset have also been reported as adverse events of corticosteroid treatment

8. Answer False

Unlike prescription drugs and medications, the dietary supplements does not require FDA approval and also does not required to prove its safety and efficacy to the regulatory authorities. It is the responsibility of the manufacturer to ensure that the claims are true and the safety and usability of their products at a dietary supplement is being maintained and safe for public use.

9. Answer Option A. Acetylcholine

Option A is correct as ward medication in use for Alzheimer's treatment help by increasing the level of neurotransmitter known as acetylcholine which helps in nerve cell communication and also help with the symptoms of dementia while improving the neural network and communications with increased level of acetylcholine

Option B is incorrect as both the medication are not known to have increased level of dopamine in Alzheimer's treatment

Option C is incorrect as epinephrine levels are not increase on administration of both drugs in Alzheimer's treatment and are not relevant to the treatment of the disease

Option D is incorrect as levels of histamine increased by both the drugs are not known effects in Alzheimer treatment and does not aligneffect of the drugs in Alzheimer's treatment.